0000929638-23-001714.txt : 20230609 0000929638-23-001714.hdr.sgml : 20230609 20230609171308 ACCESSION NUMBER: 0000929638-23-001714 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230608 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Torrente Josephine CENTRAL INDEX KEY: 0001886711 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36464 FILM NUMBER: 231006306 MAIL ADDRESS: STREET 1: 101 POOR FARM ROAD CITY: PRINCETON STATE: NY ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGILE THERAPEUTICS INC CENTRAL INDEX KEY: 0001261249 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 COLLEGE ROAD EAST STREET 2: SUITE 310 CITY: PRINCETON STATE: NJ ZIP: 08540-6635 BUSINESS PHONE: 609-683-1880 MAIL ADDRESS: STREET 1: 500 COLLEGE ROAD EAST STREET 2: SUITE 310 CITY: PRINCETON STATE: NJ ZIP: 08540-6635 4 1 form4.xml X0407 4 2023-06-08 0001261249 AGILE THERAPEUTICS INC AGRX 0001886711 Torrente Josephine 500 COLLEGE ROAD EAST, SUITE 310 PRINCETON NJ 08540 true false Common Stock 2023-06-08 4 A 0 935 0 A 988 D Employee Stock Option (Right to Buy) 3.58 2023-06-08 4 A 0 1065 0 A 2033-06-07 Common Stock 1065 1065 D These shares represent restricted stock units that were granted on June 8, 2023, which will vest and be settled in common stock on June 8, 2024, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service. On April 10, 2023 the Issuer completed a one-for-fifty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split. This option was granted on June 8, 2023 and vests in full on June 8, 2024, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service. /s/ Geoffrey P. Gilmore, Attorney-in-fact 2023-06-09